1. Home
  2. MEHA vs PFSA Comparison

MEHA vs PFSA Comparison

Compare MEHA & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MEHA

Functional Brands Inc.

N/A

Current Price

$0.23

Market Cap

3.4M

Sector

Health Care

ML Signal

N/A

PFSA

Profusa Inc.

N/A

Current Price

$1.21

Market Cap

3.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MEHA
PFSA
Founded
2020
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4M
3.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MEHA
PFSA
Price
$0.23
$1.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
590.6K
2.0M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$0.05
52 Week High
$0.74
$4.22

Technical Indicators

Market Signals
Indicator
MEHA
PFSA
Relative Strength Index (RSI) 53.68 51.18
Support Level $0.18 $0.19
Resistance Level $0.24 $2.22
Average True Range (ATR) 0.02 0.35
MACD 0.01 -0.10
Stochastic Oscillator 80.14 27.82

Price Performance

Historical Comparison
MEHA
PFSA

About MEHA Functional Brands Inc.

Functional Brands Inc operates in the nutraceutical supplement industry. It is a manufacturer and distributor of supplements in categories such as pain, energy, prenatal, general health, bone and joint, gastro, immunity, cardiac, detox, brain and memory, sleep, prenatal and urinary. It is focus on end-consumers through different channels that include pharmacies, wholesalers, international distributors and direct-to-consumers sales. The Company has two reportable segments: 1) Kirkman, which sells a range of nutraceuticals, supplements and related products direct to consumers; 2) HT Naturals, which sells a range of hemp products; and 3) Corporate, which generates no revenue. Key revenue is generated from Kirkman.

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

Share on Social Networks: